Dentsply Sirona Inc
XRAY: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$52.00 | Rwpdg | Fnfxvnzn |
Dentsply Sirona's Stabilizing Q4 Performance and Positive Guidance Boost Shares
Dentsply Sirona reported fourth-quarter results that reflected a notable stabilization in its business. Improving core results and management’s positive 2021 outlook provided a boost to the shares, which traded 13% higher on March 1. The business had struggled through the pandemic, and its recovery has been slower than peers'; this was probably exacerbated by the company's restructuring efforts, which started before the pandemic, and its largely commodity portfolio. We do not anticipate a material change to our $40 value estimate for no-moat Dentsply.